Decreased postpartum exercise capacity after a diagnosis of pre-eclampsia: Implications for CVD risk prediction – ScienceDirect ABSTRACT Background Hypertensive disorders of pregnancy (HDP) are associated with increased long-term risk for…
Objective: Trends in risk factors have not been evaluated since a study in a single medical center using data from 1988 to 2014.2 Thus, this study evaluated trends in preeclampsia risk…
Read More from JAMA: Trends in Preeclampsia Risk Factors in the US From 2010 to 2021
Adverse Pregnancy Outcomes and Predicted 30-Year Risk of Mat… : Obstetrics & Gynecology (lww.com) OBJECTIVE: To determine whether adverse pregnancy outcomes are associated with a higher predicted 30-year risk of…
Clinical Opinion: Toward the elimination of race-based medicine: replace race with racism as preeclampsia risk factor Pregnancy-related morbidity and mortality continue to disproportionately affect birthing people who identify as Black….
ABSTRACT Background The rate of cesarean delivery is continuously increasing with the leading indication being a previous cesarean delivery. For women with 1 previous cesarean delivery, it is generally agreed…
Read More from AJOG: Timing of cesarean delivery in women with ≥2 previous cesarean deliveries
ABSTRACT OBJECTIVE To examine the relationship between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy and the risk of preeclampsia. DATA SOURCES MEDLINE, EMBASE, POPLINE, CINAHL, LILACS, and…
Maternal tolerance of the semiallogenic fetus necessitates conciliation of competing interests. Viviparity evolved with a placenta to mediate the needs of the fetus and maternal adaptation to the demands of…
Abstract Hypertensive disorders of pregnancy constitute one of the leading causes of maternal and perinatal mortality worldwide. It has been estimated that preeclampsia complicates 2–8% of pregnancies globally (1). In…
Read More from ACOG Practice Bulletin No. 22: Gestational Hypertension and Preeclampsia
Abstract Preeclampsia is a major cause of maternal and perinatal morbidity and mortality. Early onset disease requiring preterm delivery is associated with a higher risk of complications in both mothers…
Read More from AJOG: First trimester preeclampsia screening and prediction
ABSTRACT OBJECTIVE: To evaluate the cost effectiveness of various preeclampsia screening and aspirin prophylaxis strategies, including a strategy based on biomarker and ultrasound measures. METHODS: We designed a decision analysis to compare…
ABSTRACT OBJECTIVE: To describe the clinical characteristics of stroke and opportunities to improve care in a cohort of preeclampsia-related maternal mortalities in California. METHODS: The California Pregnancy-Associated Mortality Review retrospectively examined a…
Read More from ACOG: Systolic Hypertension, Preeclampsia-Related Mortality, and Stroke in California
OBJECTIVE: To describe quality improvement opportunities (QIOs) associated with the five leading causes of pregnancy-related death in California (cardiovascular disease, preeclampsia/eclampsia, hemorrhage, venous thromboembolism, and sepsis) and the methods by…
OBJECTIVE: To evaluate temporal trends in use of antihypertensive medications during delivery hospitalizations complicated by preeclampsia and risk of maternal stroke over the same time period. Click here to read the…
Preeclampsia accounts for 12% – 16% of maternal deaths in the United States, and 15% of preterm births. According to the US Preventive Services Task Force, an effective, inexpensive, and…
A March of Dimes Professional Education Webinar on “Saving lives: preventing preeclampsia with low-dose aspirin” will be held on January 8, 1-1:30 CST. Although the webinar is not only intended…
Read More from March of Dimes: Saving Lives – Preventing Preeclampsia With Low-Dose Aspirin Webinar
Presenters: Eleni Tsigas Executive Director, Preeclampsia Foundation Jessica Deeb MS, RN, WHNP-BC, IBCLC, LCCE Perinatal Quality, Risk, and Safety Program Coordinator, NYU Langone Medical Center; Lamaze Certified Childbirth Educator Click here…
Read More from Safety Action Series: Maternal Early Warning Signs: Preeclampsia
Women in the United States are unnecessarily dying from pregnancy-related complications, including preeclampsia, at a higher rate than women in 47 other countries. Together we can work to put an…
Read More from Action Alert! Preventing Maternal Deaths Act of 2017
PRESERVE-1 is a Phase 3 clinical study for women who develop preeclampsia between weeks 23-30 of gestation requiring inpatient hospitalization and eligible for expectant management. This study will assess if…
Read More from Advances in Preeclampsia: OU Enrolling Patients in Phase 3 Preeclampsia Study